These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 23466671

  • 1. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
    Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK.
    Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
    [Abstract] [Full Text] [Related]

  • 2. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
    Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK.
    Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
    [Abstract] [Full Text] [Related]

  • 3. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [Abstract] [Full Text] [Related]

  • 4. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T, Farrant C, Wise MR.
    Cochrane Database Syst Rev; 2020 Sep 06; 9(9):CD012658. PubMed ID: 32909630
    [Abstract] [Full Text] [Related]

  • 5. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia<sup/>.
    Marnach ML, Butler KA, Henry MR, Hutz CE, Langstraat CL, Lohse CM, Casey PM.
    J Womens Health (Larchmt); 2017 Apr 06; 26(4):368-373. PubMed ID: 27901412
    [Abstract] [Full Text] [Related]

  • 6. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N.
    Cochrane Database Syst Rev; 2018 Dec 04; 12(12):CD009458. PubMed ID: 30521671
    [Abstract] [Full Text] [Related]

  • 7. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
    Abu Hashim H, Ghayaty E, El Rakhawy M.
    Am J Obstet Gynecol; 2015 Oct 04; 213(4):469-78. PubMed ID: 25797236
    [Abstract] [Full Text] [Related]

  • 8. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
    El Behery MM, Saleh HS, Ibrahiem MA, Kamal EM, Kassem GA, Mohamed Mel S.
    Reprod Sci; 2015 Mar 04; 22(3):329-34. PubMed ID: 25001020
    [Abstract] [Full Text] [Related]

  • 9. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.
    Buttini MJ, Jordan SJ, Webb PM.
    Aust N Z J Obstet Gynaecol; 2009 Jun 04; 49(3):316-22. PubMed ID: 19566568
    [Abstract] [Full Text] [Related]

  • 10. Prediction of regression and relapse of endometrial hyperplasia with conservative therapy.
    Gallos ID, Ganesan R, Gupta JK.
    Obstet Gynecol; 2013 Jun 04; 121(6):1165-1171. PubMed ID: 23812448
    [Abstract] [Full Text] [Related]

  • 11. Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.
    Ørbo A, Arnes M, Vereide AB, Straume B.
    BJOG; 2016 Aug 04; 123(9):1512-9. PubMed ID: 26630538
    [Abstract] [Full Text] [Related]

  • 12. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA, Young K, Hickey M, Su HI.
    Cochrane Database Syst Rev; 2020 Dec 21; 12(12):CD007245. PubMed ID: 33348436
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.
    Wan YL, Holland C.
    Climacteric; 2011 Dec 21; 14(6):622-32. PubMed ID: 22017273
    [Abstract] [Full Text] [Related]

  • 14. Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort study.
    Gallos ID, Devey J, Ganesan R, Gupta JK.
    Gynecol Oncol; 2013 Jul 21; 130(1):58-63. PubMed ID: 23603367
    [Abstract] [Full Text] [Related]

  • 15. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Bofill Rodriguez M, Lethaby A, Jordan V.
    Cochrane Database Syst Rev; 2020 Jun 12; 6(6):CD002126. PubMed ID: 32529637
    [Abstract] [Full Text] [Related]

  • 16. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.
    Wildemeersch D, Janssens D, Pylyser K, De Wever N, Verbeeck G, Dhont M, Tjalma W.
    Maturitas; 2007 Jun 20; 57(2):210-3. PubMed ID: 17270370
    [Abstract] [Full Text] [Related]

  • 17. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
    Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, Lee JH, Ju W, Song ES, Park H, Ryu HS, Lee C, Kang SB.
    Int J Gynecol Cancer; 2016 May 20; 26(4):711-5. PubMed ID: 26905333
    [Abstract] [Full Text] [Related]

  • 18. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
    Haoula ZJ, Walker KF, Powell MC.
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov 20; 159(1):176-9. PubMed ID: 21741152
    [Abstract] [Full Text] [Related]

  • 19. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S, Hickey M, Chin J, Su HI.
    Cochrane Database Syst Rev; 2015 Dec 09; 2015(12):CD007245. PubMed ID: 26649916
    [Abstract] [Full Text] [Related]

  • 20. Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study.
    Scarselli G, Bargelli G, Taddei GL, Marchionni M, Peruzzi E, Pieralli A, Mattei A, Buccoliero AM, Fambrini M.
    Fertil Steril; 2011 Jan 09; 95(1):420-2. PubMed ID: 20723889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.